Why the study?
Does BMI status modify the effects of antihypertensive medications on BP control or cardiovascular disease outcomes in normal-weight, overweight, and obese hypertensive patients?
Does BMI status modify the effects of antihypertensive medications on BP control or cardiovascular disease outcomes in normal-weight, overweight, and obese hypertensive patients?
The efficacy of antihypertensive medications on blood pressure control and cardiovascular outcomes is consistent regardless of a patient's BMI status.
Supports uniform antihypertensive effects across BMI categories; confirms no modification of BP or CVD outcomes in this RCT.
BMI status does not modify the effects of antihypertensive medications on BP control or cardiovascular disease outcomes.
No takes yet. Share an insight, caveat, or question.
Reisin et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: